Related Experiment Videos
Outcomes in sinonasal mucosal melanoma
Jarad M Martin1, Sandro Porceddu, LeAnn Weih
1Head and Neck Unit, Division of Radiation Oncology, Peter MacCallum Cancer Centre, St Andrews Place, East Melbourne, Australia. jarad.martin@petermac.org <jarad.martin@petermac.org>
ANZ Journal of Surgery
|October 1, 2004
Summary
Outcomes for sinonasal mucosal melanoma (SNMM) are poor with current treatments. Early-stage disease may benefit from aggressive therapy, while advanced stages show limited survival rates.
Area of Science:
- Oncology
- Head and Neck Surgery
- Melanoma Research
Background:
- Sinonasal mucosal melanoma (SNMM) is a rare and aggressive malignancy.
- Treatment outcomes for SNMM are historically poor.
Purpose of the Study:
- To assess treatment outcomes in patients with sinonasal mucosal melanoma (SNMM).
- To evaluate the efficacy of conventional therapies for SNMM.
Main Methods:
- Retrospective review of 20 SNMM patients treated between 1991 and 2002.
- Analysis of treatment modalities including surgery and radiotherapy.
- Determination of patient outcomes, including disease recurrence and survival rates.
Main Results:
- Most patients (17/20) had nasal cavity involvement; none presented with nodal or distant metastasis.
- Surgery followed by radiotherapy was the most common treatment (15/20).
- Median overall survival was 17 months, with a 2-year survival of 23%. Advanced tumors (T3-4) had a 4.3 times higher risk of death.
Conclusions:
- Conventional therapy yields poor outcomes for sinonasal mucosal melanoma.
- Comprehensive staging before treatment is crucial.
- Aggressive treatment is only justified for early-stage SNMM due to significant morbidity.